Anti-Inflammatory and Antimicrobial Roles of Secretory Leukocyte Protease Inhibitor
Top Cited Papers
Open Access
- 1 March 2005
- journal article
- review article
- Published by American Society for Microbiology in Infection and Immunity
- Vol. 73 (3) , 1271-1274
- https://doi.org/10.1128/iai.73.3.1271-1274.2005
Abstract
No abstract availableKeywords
This publication has 70 references indexed in Scilit:
- Up-Regulation of Secretory Leukocyte Protease Inhibitor (SLPI) in the Brain after Ischemic Stroke: Adenoviral Expression of SLPI Protects Brain from Ischemic InjuryMolecular Pharmacology, 2003
- Salivary Secretory Leukocyte Protease Inhibitor Is Associated with Reduced Transmission of Human Immunodeficiency Virus Type 1 through Breast MilkThe Journal of Infectious Diseases, 2002
- Effect of Menstrual Status on Antibacterial Activity and Secretory Leukocyte Protease Inhibitor Production by Human Uterine Epithelial Cells in CultureThe Journal of Infectious Diseases, 2002
- Secretory leukoprotease inhibitor: a native antimicrobial protein presenting a new therapeutic option?Thorax, 1998
- Secretory leukocyte protease inhibitor blocks infectivity of primary monocytes and mononuclear cells with both monocytotropic and lymphocytotropic strains of human immunodeficiency virus type 1Oral Diseases, 1997
- Secretory leukocyte protease inhibitor (SLPI) in mucosal fluids inhibits HIV‐1Oral Diseases, 1997
- Separation of the two domains of human mucus proteinase inhibitor: Inhibitory activity is only located in the car☐y-terminal domainBiochemical and Biophysical Research Communications, 1991
- Tissue distribution of antileukoprotease and lysozyme in humans.Journal of Histochemistry & Cytochemistry, 1989
- The acid‐stable proteinase inhibitor of human mucous secretions (HUSI‐I, antileukoprotease)FEBS Letters, 1986
- Quantitation Of Human Granulocyte Protease Inhibitors In Non-Purulent Bronchial Lavage FluidsActa Oto-Laryngologica, 1978